COVID-19疫苗与妊娠:产科医生需知
本文综述了COVID-19疫苗在妊娠期应用的问题。因孕妇被排除在初始3期临床试验之外,妊娠期有效性和安全性数据有限。CDC、ACOG和SMFM均发布指南支持为孕妇提供COVID-19疫苗,产科医生需利用现有数据权衡利弊并持续更新信息。
要点
- 孕妇被排除在COVID-19疫苗初始3期临床试验外,妊娠期数据有限
- CDC、ACOG和SMFM均支持为孕妇提供COVID-19疫苗
- 咨询需考虑动物研究数据、疫苗反应原性风险、接种时机及暴露风险
核心结论
- CDC、ACOG和SMFM均发布指南支持为孕妇提供COVID-19疫苗。
研究设计与样本
- 本文为综述,总结COVID-19疫苗在妊娠期应用的相关证据与指南。
主要发现
- 孕妇被排除在COVID-19疫苗初始3期临床试验之外,妊娠期有效性和安全性数据有限。
- 部分公司在完成发育和生殖毒理学研究后预计将开展孕妇临床试验。
关键数值与推荐
- CDC、ACOG和SMFM均发布指南支持为孕妇提供COVID-19疫苗。
临床怎么用
- 产科医生应利用现有数据权衡COVID-19疫苗对孕妇的获益与风险。
- 咨询应涵盖动物研究数据、疫苗反应原性对妊娠的潜在风险、接种时机、其他疫苗孕期安全性证据、COVID-19并发症风险及SARS-CoV-2暴露风险。
- 产科医生需持续更新临床试验和接种孕妇收集的数据。
局限性
- 孕妇被排除在初始3期临床试验之外,妊娠期有效性和安全性数据有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Coronavirus disease 2019 (COVID-19) vaccines have begun to be distributed across the United States and to be offered initially to priority groups including health care personnel and persons living in long-term care facilities. Guidance regarding whether pregnant persons should receive a COVID-19 vaccine is needed. Because pregnant persons were excluded from the initial phase 3 clinical trials of COVID-19 vaccines, limited data are available on their efficacy and safety during pregnancy. After developmental and reproductive toxicology studies are completed, some companies are expected to conduct clinical trials in pregnant persons. Until then, pregnant persons and their obstetricians will need to use available data to weigh the benefits and risks of COVID-19 vaccines. Issues to be considered when counseling pregnant persons include data from animal studies and inadvertently exposed pregnancies during vaccine clinical trials when available, potential risks to pregnancy of vaccine reactogenicity, timing of vaccination during pregnancy, evidence for safety of other vaccines during pregnancy, risk of COVID-19 complications due to pregnancy and the pregnant person's underlying conditions, and risk of exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and potential for risk mitigation. The Centers for Disease Control and Prevention, the American College of Obstetricians and Gynecologists, and the Society for Maternal-Fetal Medicine have each issued guidance supportive of offering COVID-19 vaccine to pregnant persons. As additional information from clinical trials and from data collected on vaccinated pregnant persons becomes available, it will be critical for obstetricians to keep up to date with this information.
引用
- Rasmussen SA, Kelley CF, Horton JP, et al. Coronavirus Disease 2019 (COVID-19) Vaccines and Pregnancy: What Obstetricians Need to Know. Obstet Gynecol. 2021. PMID: 33370015. doi:10.1097/AOG.0000000000004290
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。